Schedule 13G ownership disclosure

Nektar Therapeutics

Common Stock, $0.0001 par value per share · CUSIP: 640268306

Event date: 2025-09-30

Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.

Filing-level shares
Unavailable
Percent of class
Unavailable
  • Susquehanna Portfolio Strategies, LLC

    Shares: 1,235,864 · Class: 6.3%

  • Susquehanna Securities, LLC

    Shares: 1,235,864 · Class: 6.3%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001446580-25-000123
Form type
SCHEDULE 13G
Filer
NEKTAR THERAPEUTICS
CIK
CIK 906709
Filed
Nov 13, 2025
Reporting period
Sep 30, 2025
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub